NCT04359147View on ClinicalTrials.gov

The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat

NACompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

December 22, 2021

Study Completion Date

December 22, 2021

Conditions
YohimbineHydrocortisoneYohimbine + HydrocortisonePlacebo
Interventions
DRUG

"Yohimbine"

Effects on neural correlates of decision-making under risk and selective attention to threat

DRUG

"Hydrocortisone"

Effects on neural correlates of decision-making under risk and selective attention to threat

DRUG

"Yohimbine + Hydrocortisone"

Effects on neural correlates of decision-making under risk and selective attention to threat

DRUG

"Placebo"

Effects on neural correlates of decision-making under risk and selective attention to threat

Trial Locations (1)

Unknown

Charite University, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT04359147 - The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat | Biotech Hunter | Biotech Hunter